BICO Group AB (publ) (BCCOY)
OTCMKTS · Delayed Price · Currency is USD
0.5500
0.00 (0.00%)
At close: Oct 2, 2025
BICO Group AB Market Cap
BICO Group AB has a market cap or net worth of $162.00 million as of October 6, 2025. Its market cap has decreased by -49.62% in one year.
Market Cap
162.00M
Enterprise Value
246.05M
Revenue
185.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.55
Market Cap Chart
Since November 3, 2016, BICO Group AB's market cap has increased from 34.36M to 162.00M, an increase of 371.47%. That is a compound annual growth rate of 18.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 163.10M | -20.28% |
| Dec 30, 2024 | 204.60M | -48.67% |
| Dec 29, 2023 | 398.59M | -44.29% |
| Dec 30, 2022 | 715.50M | -62.50% |
| Dec 30, 2021 | 1.91B | 29.22% |
| Dec 30, 2020 | 1.48B | 322.83% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |